Cannabis Sativa Monograph Pdf File
Established in 1995, the American Herbal Pharmacopoeia (AHP) is a non-profit 501(c)(3) California- based organization with a mission to promote the responsible use of herbal products and herbal medicines. The AHP produces critically reviewed documents called monographs that outline the quality control criteria needed for ensuring the identity, purity, and quality of botanical raw materials. Each monograph also presents a complete and critical review of the traditional and scientific literature regarding the efficacy and safety of herbal medicines and includes information on specific products such as tinctures and extracts. In 2011, the AHP began the development of a Cannabis Monograph and a Therapeutic Compendium for Cannabis. The first edition of the Cannabis Monograph was released in 2013 and provides scientifically valid standards for companies engaged in laboratory analysis of cannabis, cannabis-derived products and hemp products with regards to:. Ensuring the identity, quality, purity, and potency of cannabis, cannabis-derived and hemp products;.
Reporting, analytic equipment calibration and method validation;. And, ensuring product safety by identifying safe levels of pesticides, metals, and microbial limits.
Hemp Cannabis Sativa
Cannabis flos, ssp. Sativa, variety Bedrocan (hemp flowers). Market: to be sold on the pharmaceutical market. Strength: dronabinol: approx. 22% cannabidiol:%. Dosage form: flowers. Package size: 5 grams in containers, 250 grams in bags. Brown green clustered.
Currently in the Cannabis analytical world, different analysts are using different technologies and methods and reporting their results, such as quantitation of THC, in different ways that are often not scientifically valid. They then use those analytical results to claim some level of superiority, such as higher THC values, which dispensaries and patients or product manufacturers use to influence buying decisions. However, every technology and method gives different results so the values being reported are not consistent and so buying choices are often made on inaccurate information. Adherence to a monograph standard ensures that results are consistent and findings are accurate.
Most popular information is generated from inaccurate or imprecise extrapolations of the benefit or potential benefit of Cannabis as reflected in pharmacological research. Much of this research is exploratory and may not have any relevance to human clinical use. Additionally, reporting biases heavily influence many sources of information, popular and scientific. Pro-Cannabis reporting often exaggerate the potential benefits of the botanical, while anti-Cannabis reporting will often negate any potential benefit.
Cannabis Sativa Seed Oil Toxicity
The truth is usually somewhere in the middle. A key element of the AHP Therapeutic Compendium is that it will be reviewed by multi-disciplinary groups of reviewers representing herbal and naturopathic medicine on the traditional use side and medical doctors, pharmacists, pharmacologists and toxicologists on the science side. When completed the Therapeutic Compendium will represent one of the most comprehensive and balanced reviews of the totality of the Cannabis literature anywhere in the world.
Comments are closed.